PhaseBio Pharmaceuticals Inc (PHASQ)
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiovascular diseases. The firm's pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor, pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension, and PB6440, an oral agent for the treatment of resistant hypertension. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp on January 10, 2002 and is headquartered in Dover, DE.
Address
1 GREAT VALLEY PARKWAY
MALVERN, PA 19355
Founded
2002
Number of Employees
-
Website
http://www.phasebio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)